The Tecnis PureSee IOL is the first FDA-approved extended depth of focus IOL maintaining contrast sensitivity comparable to ...

Johnson & Johnson (NYSE: JNJ) announced that it received FDA approval for its Tecnis PureSee intraocular lens (IOL) for cataract surgery.

FDA approval supports US commercialization of TECNIS PureSee, an EDOF IOL for implantation during cataract surgery, with availability anticipated later in 2026. PureSee is positioned to preserve ...

TECNIS PureSee IOL197% of patients would recommend this IOL to friends or family2TECNIS PureSee IOL is the first and only U.S. FDA-approved extended depth of focus (EDOF) IOL maintaining contrast ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The first commercial phacoemulsification procedure with ...

Please provide your email address to receive an email when new articles are posted on . Phakic lens implants are useful for the treatment of high degrees of myopia, which are beyond the capabilities ...

Cataract surgery remains one of the most frequently performed and successful surgical procedures worldwide, involving the removal of a clouded natural lens and its replacement with an intraocular lens ...

The following Q&A comes from the Centers for Medicare & Medicaid Services website. Q: What is the payment policy for an Astigmatism-Correcting Intraocular Lens (A-C IOL) inserted following removal of ...

“As the global leader in eye care, we are committed to improving our technologies to advance patient outcomes through rigorous, world-class R&D—even with our leading products like PanOptix,” said Rob ...

Cataract surgery is linked with lower falls and reductions in fall-related traumatic injuries in older adults, a new study finds. Authors of the report, published Tuesday in the Journal of the ...